AAQ1 — aap Implantate AG Share News
0.000.00%
Last trade - 00:00- €24.72m
- €23.67m
- €12.49m
Brief: Aap Implantate FY 2019 Sales Up At EUR 11.7 Mln
Brief: Aap Implantate Gets Funding For Its Antibacterial Silver Coating Technology
Brief: Aap Q3 EBITDA Loss Widens To EUR 1.7 Million
Brief: Aap Implantate AG Says Adjusts Outlook For FY 2019
Brief: Aap Implantate Gets European Patent For Resorbable Magnesium Implant Technology
Brief: Aap Receives FDA Approval For Polyaxial LOQTEQ VA Foot System
Brief: Aap Implantate To Discontinue Parts Of Its Standard Trauma Business
Brief: Aap Implantate Appoints Nathalie Krebs As Supervisory Board Chairwoman
Brief: Aap Implantate Q1 EBITDA Loss Narrows To EUR 1.0 Million
Brief: Aap Implantate Completes Capital Increase
Brief: Aap Implantate FY EBITDA At Negatvie EUR 6.4 Mln
Brief: Aap Adopts Package Of Measures To Strengthen Its Financial Base
Brief: Aap Implantate Resolves On Capital Increase With Subscription Rights
Brief: Aap Implantate: CEO Bruke Seyoum Alemu To Retire Early As Of April 30
Brief: Aap Implantate: Q1 Sales At About EUR 3.5 Mln
Brief: AAP Implantate Postpones Publication Of Annual Accounts 2018
Brief: Aap Implantate FY Sales Of EUR 10.8 Million
Brief: Aap Implantate Q3 Sales Grew By 5% To EUR 2.7 Mln
Brief: Aap Implantate: Antibacterial Silver Coating Technology - Convincing Results Of Animal Study By Aap And Ao Research Institute Davos